180 related articles for article (PubMed ID: 9039595)
1. Assessing tumor angiogenesis using macromolecular MR imaging contrast media.
Brasch R; Pham C; Shames D; Roberts T; van Dijke K; van Bruggen N; Mann J; Ostrowitzki S; Melnyk O
J Magn Reson Imaging; 1997; 7(1):68-74. PubMed ID: 9039595
[TBL] [Abstract][Full Text] [Related]
2. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
Daldrup-Link HE; Okuhata Y; Wolfe A; Srivastav S; Øie S; Ferrara N; Cohen RL; Shames DM; Brasch RC
Microcirculation; 2004; 11(5):387-96. PubMed ID: 15280064
[TBL] [Abstract][Full Text] [Related]
3. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report.
Brasch R; Turetschek K
Eur J Radiol; 2000 Jun; 34(3):148-55. PubMed ID: 10927157
[TBL] [Abstract][Full Text] [Related]
4. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
Cyran CC; Sennino B; Fu Y; Rogut V; Shames DM; Chaopathomkul B; Wendland MF; McDonald DM; Brasch RC; Raatschen HJ
Eur J Radiol; 2012 May; 81(5):891-6. PubMed ID: 21889860
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.
Cyran CC; Sennino B; Chaopathomkul B; Fu Y; Rogut V; Shames DM; Wendland MF; McDonald DM; Brasch RC
Invest Radiol; 2008 May; 43(5):298-305. PubMed ID: 18424950
[TBL] [Abstract][Full Text] [Related]
6. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.
Turetschek K; Preda A; Floyd E; Shames DM; Novikov V; Roberts TP; Wood JM; Fu Y; Carter WO; Brasch RC
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):448-55. PubMed ID: 12722742
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
Cyran CC; Fu Y; Rogut V; Chaopathomkul B; Wendland MF; Shames DM; Brasch RC
Acad Radiol; 2013 Oct; 20(10):1256-63. PubMed ID: 24029057
[TBL] [Abstract][Full Text] [Related]
8. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP
J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
[TBL] [Abstract][Full Text] [Related]
9. MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats.
Fournier LS; Novikov V; Lucidi V; Fu Y; Miller T; Floyd E; Shames DM; Brasch RC
Radiology; 2007 Apr; 243(1):105-11. PubMed ID: 17329684
[TBL] [Abstract][Full Text] [Related]
10. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
[TBL] [Abstract][Full Text] [Related]
11. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
[TBL] [Abstract][Full Text] [Related]
12. Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.
Sennino B; Raatschen HJ; Wendland MF; Fu Y; You WK; Shames DM; McDonald DM; Brasch RC
Magn Reson Med; 2009 Sep; 62(3):616-25. PubMed ID: 19526501
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.
Roberts HC; Roberts TP; Brasch RC; Dillon WP
AJNR Am J Neuroradiol; 2000 May; 21(5):891-9. PubMed ID: 10815665
[TBL] [Abstract][Full Text] [Related]
14. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tumor angiogenesis using dynamic enhanced magnetic resonance imaging: comparison of plasma vascular endothelial growth factor, hemodynamic, and pharmacokinetic parameters.
Ikeda O; Nishimura R; Miyayama H; Yasunaga T; Ozaki Y; Tuji A; Yamashita Y
Acta Radiol; 2004 Jul; 45(4):446-52. PubMed ID: 15323399
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
[TBL] [Abstract][Full Text] [Related]
17. Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model.
Jun HY; Yin HH; Kim SH; Park SH; Kim HS; Yoon KH
Korean J Radiol; 2010; 11(4):449-56. PubMed ID: 20592929
[TBL] [Abstract][Full Text] [Related]
18. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability.
Roberts HC; Saeed M; Roberts TP; Mühler A; Shames DM; Mann JS; Stiskal M; Demsar F; Brasch RC
J Magn Reson Imaging; 1997; 7(2):331-8. PubMed ID: 9090587
[TBL] [Abstract][Full Text] [Related]
19. Macromolecular MRI contrast agents for imaging tumor angiogenesis.
Barrett T; Kobayashi H; Brechbiel M; Choyke PL
Eur J Radiol; 2006 Dec; 60(3):353-66. PubMed ID: 16930905
[TBL] [Abstract][Full Text] [Related]
20. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution.
Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
Magn Reson Med; 1997 Feb; 37(2):236-42. PubMed ID: 9001148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
